Could a simple pad replace invasive biopsies for uterine cancer?

NCT ID NCT06464107

Completed Diagnosis Sponsor: Hackensack Meridian Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special pad (PadKit™) worn for 4-6 hours to collect cells shed from the uterus. Researchers wanted to see if the pad could gather enough cells to tell the difference between normal tissue, precancerous changes, and cancer. 80 women scheduled for surgery (some with cancer or precancer, some with benign conditions) wore the pad before their procedure. The goal is to find a less invasive way to screen for endometrial cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PadKit™ (interlabial pad device)
What this could lead to: If successful, this pad could offer a simple, at-home way to screen for endometrial cancer or abnormal cell growth, reducing the need for invasive procedures.
What could go wrong: This is a small, completed feasibility study (80 participants) that only checks if the pad can collect enough cells. It does not prove the pad can reliably diagnose cancer, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer Endometrial Hyperplasia endometrium neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASMS

Contacts and locations

Locations

Jersey Shore University Medical Center

Neptune City, New Jersey, 07753, United States
Riverview Medical Center

Red Bank, New Jersey, 07701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.